|[Transbronchial lung cryobiopsy in diffuse interstitial lung disease diagnosis]|
|Klappenbach R, Augustovski F, Pichon-Riviere A, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L|
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Klappenbach R, Augustovski F, Pichon-Riviere A, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A, Rey-Ares L. [Transbronchial lung cryobiopsy in diffuse interstitial lung disease diagnosis] Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Documentos de Evaluación de Tecnologías Sanitarias, Informe de Respuesta Rapida No 516. 2017
Very low quality evidence suggests that transbronchial lung cryobiopsy for diffuse interstitial lung disease diagnosis would have a lower mortality than the videothoracoscopic lung biopsy, although with a lower diagnostic yield and a higher number of mild to moderate complications. Because of the little evidence and the lower diagnostic yield, the few CPGs mentioning cryobiopsy, describe it as a less invasive alternative for patients at high surgical risk. No coverage policies were found covering this technology.
Final publication URL
Subject indexing assigned by CRD
Humans; Lung; Lung Diseases, Interstitial
Country of organisation
There is no English language summary available.
Address for correspondence
Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 – 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: email@example.com
Date abstract record published